Artificial intelligence in diagnostic software: validation, safety, and lifecycle challenges in Europe.
New regulatory guidance clarifies how to validate and deploy AI diagnostic tools in laboratories across European healthcare systems.
This regulatory review published in Clinica Chimica Acta analyzes the challenges of validating and deploying AI diagnostic software under evolving European MDR and AI Act frameworks, proposing a structured lifecycle approach for laboratory diagnostic AI tools. The analysis is particularly relevant for laboratories implementing AI-assisted CBC interpretation, pathology reading, and clinical decision support tools across European healthcare systems.
What the study was
- Study design
- Review
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Clin Chim Acta
Why it surfaced
EU AI Act and MDR implementation is actively changing lab diagnostics landscape; regulatory review in Clin Chim Acta is relevant to AI/ML diagnostic watchlist; CBC-adjacent topic.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.